» Articles » PMID: 23437409

T Cell Hypo-responsiveness Against Leishmania Major in MAP Kinase Phosphatase (MKP) 2 Deficient C57BL/6 Mice Does Not Alter the Healer Disease Phenotype

Overview
Date 2013 Feb 26
PMID 23437409
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We have recently demonstrated that MAP kinase phosphatase 2 (MKP-2) deficient C57BL/6 mice, unlike their wild-type counterparts, are unable to control infection with the protozoan parasite Leishmania mexicana. Increased susceptibility was associated with elevated Arginase-1 levels and reduced iNOS activity in macrophages as well as a diminished T(H)1 response. By contrast, in the present study footpad infection of MKP-2(-/-) mice with L. major resulted in a healing response as measured by lesion size and parasite numbers similar to infected MKP-2(+/+) mice. Analysis of immune responses following infection demonstrated a reduced T(H)1 response in MKP-2(-/-) mice with lower parasite specific serum IgG2b levels, a lower frequency of IFN-γ and TNF-α producing CD4(+) and CD8(+) T cells and lower antigen stimulated spleen cell IFN-γ production than their wild-type counterparts. However, infected MKP-2(-/-) mice also had similarly reduced levels of antigen induced spleen and lymph node cell IL-4 production compared with MKP-2(+/+) mice as well as reduced levels of parasite-specific IgG1 in the serum, indicating a general T cell hypo-responsiveness. Consequently the overall T(H)1/T(H)2 balance was unaltered in MKP-2(-/-) compared with wild-type mice. Although non-stimulated MKP-2(-/-) macrophages were more permissive to L. major growth than macrophages from MKP-2(+/+) mice, reflecting their reduced iNOS and increased Arginase-1 expression, LPS/IFN-γ activation was equally effective at controlling parasite growth in MKP-2(-/-) and MKP-2(+/+) macrophages. Consequently, in the absence of any switch in the T(H)1/T(H)2 balance in MKP-2(-/-) mice, no significant change in disease phenotype was observed.

Citing Articles

Limited Impact of the Protein Corona on the Cellular Uptake of PEGylated Zein Micelles by Melanoma Cancer Cells.

Meewan J, Somani S, Laskar P, Irving C, Mullin M, Woods S Pharmaceutics. 2022; 14(2).

PMID: 35214171 PMC: 8877401. DOI: 10.3390/pharmaceutics14020439.


Whole Genome Microarray Analysis of DUSP4-Deletion Reveals A Novel Role for MAP Kinase Phosphatase-2 (MKP-2) in Macrophage Gene Expression and Function.

Neamatallah T, Jabbar S, Tate R, Schroeder J, Shweash M, Alexander J Int J Mol Sci. 2019; 20(14).

PMID: 31336892 PMC: 6679025. DOI: 10.3390/ijms20143434.


Novel protective role for MAP kinase phosphatase 2 in inflammatory arthritis.

Schroeder J, Ross K, McIntosh K, Jabber S, Woods S, Crowe J RMD Open. 2019; 5(1):e000711.

PMID: 30713718 PMC: 6340532. DOI: 10.1136/rmdopen-2018-000711.


Function of Macrophage and Parasite Phosphatases in Leishmaniasis.

Soulat D, Bogdan C Front Immunol. 2018; 8:1838.

PMID: 29312331 PMC: 5743797. DOI: 10.3389/fimmu.2017.01838.


MAP kinase phosphatase 2 deficient mice develop attenuated experimental autoimmune encephalomyelitis through regulating dendritic cells and T cells.

Barbour M, Plevin R, Jiang H Sci Rep. 2016; 6:38999.

PMID: 27958388 PMC: 5154199. DOI: 10.1038/srep38999.


References
1.
Shimizu Y, Yamakami K, Gomi T, Nakata M, Asanuma H, Tadakuma T . Protection against Leishmania major infection by oligomannose-coated liposomes. Bioorg Med Chem. 2003; 11(7):1191-5. DOI: 10.1016/s0968-0896(02)00644-2. View

2.
Iniesta V, Molano I, Mohedano A, Carcelen J, Miron C, Alonso C . Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol. 2002; 24(3):113-8. DOI: 10.1046/j.1365-3024.2002.00444.x. View

3.
Chen P, Hutter D, Yang X, Gorospe M, Davis R, Liu Y . Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically. J Biol Chem. 2001; 276(31):29440-9. DOI: 10.1074/jbc.M103463200. View

4.
Munder M, Choi B, Rogers M, Kropf P . L-arginine deprivation impairs Leishmania major-specific T-cell responses. Eur J Immunol. 2009; 39(8):2161-72. PMC: 2948424. DOI: 10.1002/eji.200839041. View

5.
Jaafari M, Badiee A, Khamesipour A, Samiei A, Soroush D, Kheiri M . The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome. Vaccine. 2007; 25(32):6107-17. DOI: 10.1016/j.vaccine.2007.05.009. View